newsfilter
← Latest News
FDA Approved Drugs·

Approval of Lamprene, Nda #019500 (Labeling)

Approval Date: 11/03/2026; Drug Name: Lamprene, Nda #019500; Active Ingredients: CLOFAZIMINE; Company: Novartis; Submission Status: Approval; Submission Classification: Labeling; Application Number: 019500

Company
NOVARTIS
Keywords
NOVARTIS